These hormonal shifts work together to support sustainable weight loss, stabilize blood sugar levels, and improve overall metabolic health
Notably, the insulinotropic effect of the Epac2 pathway is only significant when glucose concentrations are at or above 5.5 mM, ensuring that GIP stimulates insulin secretion primarily under hyperglycemic conditions
Currently, the Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity (SELECT) study that assesses the effect of semaglutide on cardiovascular events in non-diabetic patients with obesity and established cardiovascular diseases is ongoing [14]
Because it protects cells so effectively, it may inadvertently protect cells that medical treatments are trying to target
Clinical studies demonstrate Abdominal Relief: 63% of participants in the test group reported complete resolution of discomfort in 5 days vs 13% in the placebo group Constipation Resolution: improvement for 98.6% of study participants IBS Symptom Reduction: Significant improvements in bloating/cramping (78%), diarrhea/constipation (64%) & abdominal pain (80%) Regulatory Confidence After a rigorous scientific review of its safety and efficacy, SEBiotic was granted a GRAS (Generally Recognized as Safe) No Objections Letter from the FDA
Tell your doctor or pharmacist if any effect persists or worries you
